PV Bulletin

New e-Learning Modules for GCP Inspection Program by TGA

The Therapeutic Goods Administration (TGA) has launched interactive e-learning modules designed to clarify regulatory obligations related to Good Clinical Practice (GCP) inspections in Australia.

PV Impact Brief

Urgency: HighConfidence: high

What changed

The TGA introduced new e-learning modules specifically detailing the Good Clinical Practice (GCP) Inspection Program and the expectations for sponsors and investigators during inspections.

Why it matters

These educational resources aim to enhance the understanding of GCP compliance, which is critical for ensuring safety in clinical trials and maintaining regulatory standards.

Action needed

Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.

Relevant for
Regulatory Intelligence LeadPV Quality LeadQPPV
Processes impacted
Inspection ReadinessCountry Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Notice
Policy status
new
Publication date
2026-07-08
Policy change
The TGA has launched new interactive e-learning modules designed to help stakeholders understand their regulatory obligations, including a specific module on the TGA's Good Clinical Practice (GCP) Inspection Program. The module explains the purpose of the inspection program and what sponsors and investigators should expect during an inspection.

Key changes

Launch of the 'Getting started: TGA's Good Clinical Practice (GCP) Inspection Program' module; provides practical examples and context for compliance with GCP standards in Australia.

Affected workflows

Inspection ReadinessCountry Compliance

Responsible groups

Clinical OperationsQuality AssuranceRegulatory Affairs

PV impact

Sponsors and clinical trial teams can use this new official resource to improve inspection readiness for GCP audits. The guidance clarifies the TGA's approach to inspecting safety reporting and trial oversight, which is essential for compliance with clinical trial safety obligations.

View regulator source

Evidence and confidence

Confidence: highSource updated: Jul 8, 2026

Full briefing

Practical implication

Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.

The TGA's new interactive e-learning modules assist stakeholders, especially sponsors and clinical trial teams, in understanding their regulatory obligations and improving their readiness for GCP audits. The modules provide clarity on the inspection process and emphasize the importance of compliance with safety reporting and trial oversight requirements.

What changed: The TGA introduced new e-learning modules specifically detailing the Good Clinical Practice (GCP) Inspection Program and the expectations for sponsors and investigators during inspections.

Why it matters: These educational resources aim to enhance the understanding of GCP compliance, which is critical for ensuring safety in clinical trials and maintaining regulatory standards.

Practical implication: Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward